Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: Structure and function of the PC-1 family

Immunological Reviews

Volumn 161, Issue , 1998, Pages 11-26

  Goding, James W ^a   Terkeltaub, Robert ^b   Maurice, Michele ^c   Deterre, Philippe ^d   Sali, Adnan ^a   Belli, Sabina I ^e  

^a ALFRED HOSPITAL   (Australia)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c INSERM   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; LYMPHOCYTE ENZYME; NUCLEOTIDASE; NUCLEOTIDE PYROPHOSPHATASE; PHOSPHATASE; PHOSPHODIESTERASE; PHOSPHODIESTERASE I;

CALCIFICATION; CARTILAGE CELL; EPIDIDYMIS; GENETIC CONSERVATION; HUMAN; KIDNEY DISTAL TUBULE; LIVER CELL; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REVIEW; SEROLOGY; STRUCTURE ACTIVITY RELATION;

EID: 0031885056     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01568.x     Document Type: Review

References (98)

1. Talmage DW. Allergy and immunology. Annu Rev Med 1957;8:239-256.
2. Burnet FM. A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust J Sci 1957;20:67-69.
3. Miller JFAP. Immunological function of the thymus. Lancet 1961;ii:748-749.
4. Mitchell GF, Miller JFAP. Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes. J Exp Med 1968;118:821-837.
5. Roitt IM, Greaves MF, Torrigiani G, Brostoff J, Playfair JHL. The cellular basis of immunological responses. Lancet 1969;2:367-371.
6. Boyse EA, Miyazawa M, Aoki T, Old LJ. Ly-A and Ly-B: Two systems of lymphocyte isoantigens in the mouse. Proc R Soc Lond B 1968;178:175-193.
7. Boyse EA, Old LJ, Stocken E. An approach to the mapping of antigens on the cell surface. Proc Natl Acad Sci USA 1968;60:886-893.
8. Boyse EA, Old LJ. Some aspects of normal and abnormal cell surface genetics. Annu Rev Genet 1969;3:269-290.
9. Reif AE, Allen JMV. Specificity of isoantisera against leukemia and thymic lymphocytes. Nature 1963;200:1332-1333.
10. Raff MC. Two distinct populations of peripheral lymphocytes in mice distinguishable by immunofluorescence. Immunology 1970;19:637-650.
11. Takahashi T, Old LJ, Boyse EA. Surface alloantigens of plasma cells. J Exp Med 1970;131:1325-1341.
12. van Driel IR, Goding JW, Koch N. Plasma cell antigen PC-1 and the transferrin receptor in mouse, rat and hamster: serologic and biochemical analysis. J Immunol 1985;134:3987-3993.
13. Stearne PA, van Driel IR, Grego B, Simpson RJ, Goding JW. The murine plasma cell antigen PC-1: purification and partial amino acid sequence. J Immunol 1985;134:443-448.
14. Dumom FJ, Habbersett RC, Coker LZ, Nichols EA, Treffinger JA. High level expression of the plasma cell antigen PC. 1 on the T cell subset expanding in MRL/MpJ-Ipr/Ipr mice: detection with a xenogeneic monoclonal antibody and alloantisera. Cell Immunol 1985;96:327-337.
15. Morley DJ, Hawley DM, Ulbright TM, Butler LM, Culp JS, Hodes ME. Distribution of phosphodiesterase I in normal human tissues. J Histochem Cytochem 1987;35:75-82.
16. Harahap AR, Goding JW. Distribution of the murine plasma cell antigen PC-1 in non-lymphoid cells. J Immunol 1988;141:2317-2320.
17. Solan JL, Deftos LJ, Goding JW, Terkeltaub RA. Expression of the nucleoside triphosphate pyrophosphohydrolase PC-1 is induced by basic fibroblast growth factor (bFGF) and modulated by the activation of the protein kinase A and C pathways in osteoblast-like osteosarcoma cells. J Bone Miner Res 1996;11:183-192.
18. Belli S, Sali A, Goding JW. Divalent cations stabilize the conformation of plasma cell membrane glycoprotein PC-1 (alkaline phosphodiesterase I). Biochem J 1994;304:75-80.
19. Belli SI, Goding JW. Biochemical characterization of human PC-1, an enzyme possessing alkaline phosphodiesterase I and nudeotide pyrophosphatase activities. Eur J Biochem 1994;226:433-443.
20. van Driel IR, Goding JW. Plasma cell membrane glycoprotein PC-1; primary structure deduced from cDNA clones. J Biol Chem 1987;262:4882-4887.
21. Tung J-S, Shen F-W, Boyse EA, Fleissner E. Properties of the PC-1 molecule. Immunogenetics 1978;6:101-105.
22. Goding JW, Shen F-W. Structure of the murine plasma cell alloantigen PC-1: comparison with the receptor for transferrin. J Immunol 1982;119:2636-2640.
23. van Driel IR, Wilks AF, Pietersz GA, Goding JW. Murine plasma cell membrane antigen PC-1: Molecular cloning of cDNA and analysis of expression. Proc Natl Acad Sci USA 1985;82:8619-8623.
24. Patthy L. Detecting distant homologies of mosaic proteins. Analysis of the sequences of thrombomodulin, thrombospondin, complement proteins C9, C8a and C8b, vitronectin and the plasma cell membrane glycoprotein PC-1. J Mol Biol 1988;202:689-696.
25. Belli SI, van Driel IR, Goding JW. Identification and characterization of a soluble form of the plasma cell membrane glycoprotein PC-1 (5′-nucleotide phosphodiesterase). Eur J Biochem 1993;217:421-128.
26. Buckley MF, Loveland KA, McKinstry WJ, Garson OM, Goding JW. Plasma cell membrane glycoprotein PC-1: cDNA cloning of the human molecule, amino acid sequence and chromosomal location. J Biol Chem 1990;265:17506-17511.
27. Funakoshi I, et al. Molecular cloning of cDNAs for human fibroblast nudeotide pyrophosphatase. Arch Biochem Biophys 1992;295:180-187.
28. Rebbe N, Tong BD, Finley EM, Hickman S. Identification of nudeotide pyrophosphatase and alkaline phosphodiesterase I activity associated with the mouse plasma cell differentiation antigen PC-1. Proc Natl Acad Sci USA 1991;88:5192-5196.
29. Culp JS, Blytt HJ, Hermodson M, Butler LG. Amino acid sequence of the active site peptide of bovine intestinal 5′-nudeotide phosphodiesterase and identification of the active site residue as threonine. J Biol Chem 1985;260:8320-8324.
30. Skinner MA. Murine plasma cell antigen PC-1 has a region homologous to the active site of bovine 5′ phosphodiesterase I (EC 3.1.4.1). Nucleic Acids Res 1991;19:6049.
31. Abney ER, Evans WH, Parkhouse RME. Location of nucleotide pyrophosphatase and alkaline phosphodiesterase activities on the lymphocyte surface membrane. Biochem J 1976;159:293-299.
32. Rebbe N, Tong BD, Hickman S. Expression of nucleotide pyrophosphatase/alkaline phosphodiesterase I activities of PC-1, the murine plasma cell antigen. Mol Immunol 1993;30:87-93.
33. Beavo JA, Conti M, Heaslip RJ. Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 1994;46:399-405.
34. Muller T, Engels P, Fozard JR. Subtypes of the type 4 phosphodiesterases: structure, regulation and selective inhibition. Trends Pharmacol Sci 1996;17:294-298.
35. Engelhardt WA. Proceedings of the International Symposium of Enzyme Chemistry (Tokyo). IUB Symposium 1957;2:163-166.
36. Stanley KK, Newby AC, Luzio JP. What do ectoenzymes do? Trends Biochem Sci 1982;7:145-147.
37. Murata J, et al. cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. J Biol Chem 1994;269:30479-30484.
38. Narita M, Goji J, Nakamura H, Sano K. Molecular cloning, expression, and localization of a brain-specific phosphodiesterase I/nuclotide pyrophosphatase (PD-1α) from rat brain. J Biol Chem 1994;269:28235-28242.
39. Kawagoe H, et al. Molecular cloning and chromosomal assignment of the human brain-type phosphodiesterase I/nucleotide pyrophosphatase gene (PDNP2). Genomics 1995;30:380-384.
40. Lee HY, et al. Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin. J Biol Chem 1996;271:24408-24412.
41. RB13-6 reveals relationship to human and murine PC-1. J Biol Chem 1995;270:9849-9855.
42. Scott LJ, Delautier D, Rajho-Meerson N, Trugnan G, Goding JW, Maurice M. Biochemical and molecular identification of distinct forms of alkaline phosphodiesterase I expressed on the apical and basolateral plasma membrane surfaces of rat hepatocytes. Hepatology 1997;25:995-1002.
43. Hua PJ-H, Goding JW, Nakamura H, Sano K. Molecular cloning and chromosomal localization of PD-1β (PDNP3), a new member of human phosphodiesterase I genes. Genomics 1997;45:412-415.
44. Buckley MF, Goding JW. Plasma cell membrane glycoprotein gene Pca-1 (alkaline phosphodiesterase I) is linked to the proto-oncogene Myb on mouse chromosome 10. Immunogenetics 1992;36:199-201.
45. Tufty RM, Kretsinger RH. Troponin and parvalbumin calcium binding regions predicted in myosin light chain and T4 lysozyme. Science 1975;187:167-169.
46. Strynadka NCJ, James MNG. Crystal structure of the helix-loop-helix calcium-binding proteins. Annu Rev Biochem 1989;58:951-998.
47. Madison EL, Bird P. A vector, pSHT, for the expression and secretion of protein domains in mammalian cells. Gene 1992;121:179-180.
48. Gething M-J, Sambrook J. Protein folding in the cell. Nature 1992;355:33-45.
49. Belli SI, Mercuri FA, Sali A, Goding JW. Autophosphorylation of PC-1 (alkaline phosphodiesterase I) and analysis of the active site. Eur J Biochem 1995;228:669-676.
50. Oda Y, Kuo M-D, Huang SS, Huang JS. The plasma cell membrane glycoprotein, PC-1, is a threonine-specific protein kinase stimulated by acidic fibroblast growth factor. J Biol Chem 1991;266:16791-16795.
51. Ehrlich YH, Davis TB, Bock E, Korneki E, Lenox RH. Ecto-protein kinase activity on the external surface of neural cells. Nature 1986;320:67-70.
52. Hatmi M, Gavaret JM, Elalamy I, Vargaftig BB, Jacquemin C. Evidence for cAMP-dependent platelet ectoprotein kinase activity that phosphorylates platelet glycoprotein IV (CD36). J Biol Chem 1996;271:24776-24780.
53. Apasov SG, Smith PT, Jelonek MT, Margulies DH, Sitkovsky MV. Phosphorylation of extracellular domains of T-lymphocyte surface proteins. J Biol Chem 1996;271:25667-25683.
54. Chen W, Wieraszko A, Hogan MV, Yang H-A, Kornecki E, Ehrlich YH. Surface protein phosphorylation by ecto-protein kinase is required for the maintenance of hippocampal long-term potentiation. Proc Natl Acad Sci USA 1996;93:8688-8693.
55. Sheikh H, Isacke CM. A di-hydrophobic leuval motif regulates the basolateral localization of CD44 in polarized Madin-Darby canine kidney epithelial cells. J Biol Chem 1996;271:12185-12190.
56. Pond L, et al. A role for acidic residues in di-leucine motif-based targeting to the endocytic pathway. J Biol Chem 1995;270:19989-19997.
57. Marks MS, Ohno H, Kirchhausen T, Bonifacino JS. Protein sorting by tyrosine-based signals: adapting to the Ys and wherefores. Trends Cell Biol 1997;7:124-128.
58. Moss DW Perspectives in alkaline phosphatase research. Clin Chem 1992;38:2486-2492.
59. Russell RGG. Excretion of inorganic pyrophosphate in hypophosphatasia. Lancet 1965; ii: 461-464.
60. Zimmerman H. 5′ nucleotidase: molecular structure and functional aspects. Biochem J 1992;285:345-365.
61. Massaia M, Pileri A, Boccadoro M, Bianchi A, Palurabo A, Dianzani U. The generation of alloreactive cytotoxic T lymphocytes requires the expression of ecto-5′-nucleotidase activity. J Immunol 1988;141:3768-3775.
62. Shipp MA, Look AT. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key! Blood 1993;82:1052-1070.
63. Konkoy CS, Davis TP. Ectoenzymes as sites of peptide regulation. Trends Pharmacol Sci 1996;17:288-294.
64. White PC Disorders of aldosterone biosynthesis and action. N Engl J Med 1994;331:250-258.
65. Dombrowski KE, Ke Y, Thompson LF, Kapp JA. Antigen recognition by CTL is dependent on ecto-ATPase activity. J Immunol 1995;154:6227-6237.
66. Davidson WF, Dumont FJ, Bedigian HG, Fowlkes BJ, Morse HC. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice. J Immunol 1986;136:4075-4084.
67. Deterre P, et al. Co-ordinated regulation of CD38 and other nucleotide hydrolyzing ecto-enzymatic activities in human T-cells. J Immunol 1996;157:1381-1388.
68. Kim H, Jacobson EL, Jacobson MK. Synthesis and degradation of cyclic ADP-ribose by NAD glycohydrolases. Science 1993;261:1330-1333.
69. Muller-Steffner H, Augustin A, Schuber F. Mechanism of cyclization of pyridine nucleotides by bovine spleen NAD+ glycohydrolase. J Biol Chem 1996;271:23967-23972.
70. + glycohydrolase. Biochem J 1997 (In press).
71. Cardenal A, Masuda I, Haas AL, McCarty DJ. Specificity of a porcine 127-kD nucleotide pyrophosphohydrolase for articular tissues. Arthritis Rheum 1996;39:245-251.
72. Anderson HC. Mechanisms of pathologic calcification. Rheum Dis Clin North Am 1988;14: 303-319.
73. Lotz M, et al. Interleukin-1β suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes. Proc Natl Acad Sci USA 1995;92: 10364-10368.
74. Huang R, et al. Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone and cartilage cells: Regulation of PC-1 expression in osteosarcoma cells by transforming growth factor beta. J Clin Invest 1994;94:560-567.
75. Terkeltaub R, Rosenbach M, Fong F, Goding JW. A causal link between nucleotide pyrophosphohydrolase overactivity and increased intracellular inorganic pyrophosphate (PPi) generation is demonstrated by transfection of cultured fibroblasts and osteoblasts with PC-1 (Plasma Cell Membrane Glycoprotein-1): Relevance to CPPD deposition disease. Arthritis Rheum 1994;37:934-941.
76. Maddux BA, et al. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 1995;373:448-451.
77. Grupe A, Alleman J, Goldfine ID, Sadick M, Stewart TA. Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine. J Biol Chem 1995;270:22085-22088.
78. Stefan C, Wera S, Stalmans W, Bollen M. The inhibition of the insulin receptor by the membrane protein PC-1 is not specific and results from hydrolysis of ATP. Diabetes 1996;45:980-983.
79. Belfiore A, et al. Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity. Mol Endocrinol 1996;10:1318-1326.
80. Burnstock G, Campbell G, Satchell D, Smythe A. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non adrenergic inhibitory nerves in the gut. Br J Pharmacol 1970;40:668-688.
81. Burnstock G. Purinergic nerves. Pharmacol Rev 1972;24:509-581.
82. Olah ME, Stiles GL. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol 1995;35: 581-606.
83. Fredholm BB. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol 1995;76:93-101.
84. 2a receptor. Nature 1997;388:674-678.
85. Richardson PJ. Blocking adenosine with antisense. Nature 1997;385:684-685.
86. Zanovello P, Bronte V, Rosato A, Pizzo P, DiVirgilio F. Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. J Immunol 1990;145:1545-1550.
87. Zheng LM, Zychlinsky A, Liu C-C, Ojcius DM, Young JD-E. Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol 1991;112:279-288.
88. 2+ by receptors. Nature 1983;306:64-66.
89. Huang N, Wang D, Heppel LA. Extracellular ATP is a mitogen for 3T3, 3T6 and A431 cells and acts synergistically with other growth factors. Proc Natl Acad Sci USA 1989;86:7904-7908.
90. Hickman SE, Khoury JE, Greenberg S, Schieren I, Silverstein SC. P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages. Blood 1994;84:2452-2456.
91. Keating MT, Sanguinetti MC. Molecular genetic insights into cardiovascular disease. Science 1996;272:681-685.
92. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988;242:583-585.
93. Naquet P, Pierres M. Cell-surface enzymes and lymphocyte functions. Curr Opin Immunol 1991;3:326-329.
94. Lüthje J. Origin, metabolism and function of extracellular adenine nucleotides in the blood. Klin Wochenschr 1989;67:317-327.
95. 2+)-apyrase. J Biol Chem 1996;271:9898-9901.
96. Higgins DG, Sharp PM. CLUSTAL: a package for performing multiple sequence alignments on a microcomputer. Gene 1988;73:237-244.
97. Higgins DG, Sharp PM. Fast and sensitive multiple sequence alignments on a microcomputer. CABIOS 1989;5:151-153.
98. Shapiro M. DNADraw: A program for preparing DNA and protein data for publication. Biotechniques 1995;18:1064-1067.